Hexagon Capital Partners LLC Nuvasive Inc Transaction History

Hexagon Capital Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	BUY	$36.71 - $44.15 $2,753 - $3,311	75 Added 120.97%	137 $5,000
Q1 2023 Apr 24, 2023	SELL	$36.81 - $48.12 $2,981 - $3,897	-81 Reduced 56.64%	62 $2,000
Q4 2022 Jan 13, 2023	SELL	$35.68 - $44.71 $428 - $536	-12 Reduced 7.74%	143 $0
Q3 2022 Oct 17, 2022	BUY	$42.51 - $54.02 $3,995 - $5,077	94 Added 154.1%	155 $7,000
Q2 2022 Jul 21, 2022	BUY	$46.84 - $59.75 $2,857 - $3,644	61 New	61 $3,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Hexagon Capital Partners LLC with notifications on news.